Recent Updates
Recently added Catalysts
BLCO Positive Sentiment

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Wednesday, September 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bausch + Lomb has published new research on the enVista Aspire and enVista Aspire toric intraocular lenses. The study, featured in the journal Ophthalmology and Therapy, indicates that these lenses provide good distance and functional intermediate vision. This research underscores the effectiveness of these enhanced monofocal lenses in real-world settings.

Market Sentiment Analysis

POSITIVE FACTORS

  • New research highlights effectiveness of enVista Aspire lenses.
  • Study shows good distance and intermediate vision outcomes.
  • Research published in a reputable journal, enhancing credibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
1.4%
average across 3 past catalysts
Lead asset
Mapracorat
Phase 3 · Cataract

Full Press Release Details

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the publication of new research on real world experience with enVista Aspire and enVista Aspire toric intraocular lenses (IOLs). The study, published in the journal Ophthalmology and Therapy, found that these enhanced monofocal lenses delivered both good distance and functional intermediate vision, thus meeting

Frequently Asked Questions

What is the focus of the new research by Bausch + Lomb?

The research focuses on the real-world experience with enVista Aspire and enVista Aspire toric intraocular lenses.

Where was the study on enVista Aspire lenses published?

The study was published in the journal Ophthalmology and Therapy.

What vision outcomes do the enVista Aspire lenses provide?

The lenses provide good distance and functional intermediate vision.

Who conducted the research on enVista Aspire lenses?

The research was conducted by Bausch + Lomb Corporation.

ShareAdd on Google
Tags: BLCO Viatris Investor Conferences Healthcare Bausch + Lomb enVista Aspire intraocular lenses Ophthalmology vision health
Last updated: Sep 2, 2026

Biotech snapshot

Cash runway
$378M liquidity · $0M/mo burn
Low dilution risk
Lead asset
MapracoratPhase 3
Cataract →

Catalyst track record

+13%
best trade around BLCO's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for BLCO.

See every catalyst's timing & PoA →